Users of the video-sharing platform TikTok share and consume a melting pot of content, including viral DIY videos claiming to offer low-budget beauty and wellness tips. Among the shared and commented ...

Obesity prevalence is rising, with GLP-1 receptor agonists offering promising treatment options, yet access is limited by high costs and insurance restrictions. A study from 2021 to 2024 showed ...

More adults are taking GLP-1 drugs to control their weight, despite recent shortages and high list prices, according to new research. The percentage of overweight or obese adults prescribed a GLP-1 ...

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss. Objective: Obesity affects more than 40 ...

A 2024 KFF Health Tracking Poll found that about one in eight adults in the U.S. have used GLP-1 agonist drugs, a class of medications often turned to for weight loss and diabetes. The buzz is ...

Data and tech company Numerator has launched its GLP-1 Trends Hub, offering a centralized view of consumer GLP-1 usage, interest, purchasing behavior and demographics, the company announced Monday. As ...

Will 2026 mark the end of crash dieting? Experts reveal the truth behind weight loss myths, metabolism damage and why slow ...